RankingsPricing
  1. JP-listed companies
  2. COSMOS Pharmaceutical Corporation
  3. Financials
  4. Stockholders' equity

COSMOS Pharmaceutical Corporation【JP:3349】

Market cap
¥611.4B
P/E ratio
19.5x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndStockholders' equity (Million JPY)YoY (%)
May 31, 2025257,463+11.24%
May 31, 2024231,442+9.65%
May 31, 2023211,072+10.79%
May 31, 2022190,507+11.68%
May 31, 2021170,578+17.09%
May 31, 2020145,675+15.35%
May 31, 2019126,289+15.98%
May 31, 2018108,888+17.02%
May 31, 201793,053+22.15%
May 31, 201676,179+17.10%
May 31, 201565,055+19.59%
May 31, 201454,399+21.02%
May 31, 201344,950

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)